Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer

Molecules - Switzerland
doi 10.3390/molecules21070965
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Epithelial-Mesenchymal Transition and Drug Resistance in Breast Cancer (Review)

International Journal of Oncology
Cancer ResearchOncology
2015English

Commentary on “Epithelial–to–Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer”

Cancer Research
Cancer ResearchOncology
2016English

The Epithelial to Mesenchymal Transition (EMT) and Cancer Stem Cells: Implication for Treatment Resistance in Pancreatic Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2017English

A New Dimension in Drug Discovery: Reversing Epithelial–mesenchymal Transition (EMT)

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2016English

18P Epithelial-To-Mesenchymal Transition (EMT) Is Required for Resistance to Anti-Folate Chemotherapy in Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

The Importance of Epithelial-Mesenchymal Transition and Autophagy in Cancer Drug Resistance

2019English

Targeting Efflux Pumps to Overcome Antifungal Drug Resistance

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2016English

Molecular Profiling Supports the Role of Epithelial-To-Mesenchymal Transition (EMT) in Ovarian Cancer Metastasis

Journal of Ovarian Research
GynecologyOncologyObstetrics
2013English

Importance and Detection of Epithelial-To-Mesenchymal Transition (EMT) Phenotype in CTCs

2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy